Clinical Trials Directory

Trials / Terminated

TerminatedNCT02579733

Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Kyungpook National University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine whether azathioprine is effective for mucosal healing in UC patients who achieved clinical remission by the first course of corticosteroids but not mucosal healing in endoscopy.

Detailed description

The sample size was calculated based on the previous study showing the difference of mucosal healing rate between azathioprine (58%) and 5-aminosalicylate (21%). With a two-tailed test of α = 0.05 and 1 - ß = 0.8, 52 patients were required. The placebo drug which is identical to azathioprine will be provided by Celltrion drug company. Differences in the categorical variables between the groups are examined with χ2 or the Fisher exact test. For comparisons of continuous variables, a Student t test is used.

Conditions

Interventions

TypeNameDescription
DRUGAzathioprine
DRUGPlacebo

Timeline

Start date
2016-02-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2015-10-20
Last updated
2019-08-14

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02579733. Inclusion in this directory is not an endorsement.